Treatment method using EGFR antibodies and SRC inhibitors and related formulations
作者： Terrance Grant Johns , Webster Cavenee , Frank Furnari , Andrew Scott
DOI:
关键词:
摘要: The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination simultaneously. treatment, prevention, modulation cancer, EGFR- mediated with one more modulator inhibitor combination. further anti-EGFR antibodies inhibitors. Methods compositions for antibody anti- mAb806 series a inhibitors are described.
glgoo.top参考文章(1,060)
John Mendelsohn, Blockade of Receptors for Growth Factors: An Anticancer Therapy — The Fourth Annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Award Lecture Clinical Cancer Research. ,vol. 6, pp. 747- 753 ,(2000)
Martin W. Brechbiel, Kerrie Clarke, Andrew M. Scott, Fiona E. Smyth, Fook-Thean Lee, Lloyd J. Old, In Vivo Biodistribution of a Humanized Anti-Lewis Y Monoclonal Antibody (hu3S193) in MCF-7 Xenografted BALB/c Nude Mice Cancer Research. ,vol. 60, pp. 4804- 4811 ,(2000)
Eric A. Armstrong, Paul M. Harari, Jing Li, Shyh Min Huang, Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Research. ,vol. 62, pp. 4300- 4306 ,(2002)
K J Alligood, R J Mullin, D W Rusnak, T M Gilmer, E R Wood, B R Keith, K Affleck, D M Murray, W B Knight, K Lackey, N Rhodes, The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/ErbB-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-derived Cell Lines in Vitro and in Vivo Molecular Cancer Therapeutics. ,vol. 1, pp. 85- 94 ,(2001)
Andrew M Scott, Fook-Thean Lee, Immuno-PET for tumor targeting. The Journal of Nuclear Medicine. ,vol. 44, pp. 1282- 1283 ,(2003)
Ann Eldridge, Process for preapring maytansinol ,(2003)
Osamu Miyashita, Hiroshi Akimoto, Maytansinoids and use ,(1979)
Eiji Higashide, Seiichi Tanida, Mitsuko Asai, Process for preparing maytansinol ,(1981)
Mitsuko Asai, 20-O-Acylmaytansinoids ,(1980)
J Baselga, D Tripathy, J Mendelsohn, S Baughman, C C Benz, L Dantis, N T Sklarin, A D Seidman, C A Hudis, J Moore, P P Rosen, T Twaddell, I C Henderson, L Norton, Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Journal of Clinical Oncology. ,vol. 14, pp. 737- 744 ,(1996) , 10.1200/JCO.1996.14.3.737